Clinical Trials Logo
  1. Home
  2. Hypertension
  3. NCT05001945

Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension — Target-HTN  

Hypertension, Renal Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Phase 2 Study to Evaluate the Safety, Efficacy, and Tolerability of MLS-101 in Subjects With Uncontrolled Hypertension

Clinical Trial Summary

A randomized, double-blind, placebo-controlled, dose-ranging, Phase II study to evaluate the safety, efficacy, and tolerability of MLS-101 in Subjects With Uncontrolled Hypertension

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05001945
Study type Interventional
Source Mineralys Therapeutics Inc.
Contact
Status Completed
Phase Phase 2
Start date July 1, 2021
Completion date October 7, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT04085562 - Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis. Phase 4
Completed NCT02095691 - RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157 Phase 1
Recruiting NCT05030987 - Renal Denervation to Treat Heart Failure With Preserved Ejection Fraction N/A
Recruiting NCT05744986 - Transcatheter Renal Artery Sympathetic Denervation Observational Study
Recruiting NCT05743894 - RDN Fesibility Study
Recruiting NCT04722159 - Clinical Outcome of Patients With Resistant Hypertension Undergoing Renal Denervation
Completed NCT01756300 - RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension Phase 1
Completed NCT00446251 - Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant Phase 2
Completed NCT00490841 - The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Renal Stent to Treat Renal Artery Stenosis N/A
Recruiting NCT02432339 - Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress Phase 1/Phase 2
Completed NCT00446459 - Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant. Phase 2
Active, not recruiting NCT05807711 - Efficacy of L-methylfolate and Methylcobalamine in Treating Hypertension and Its Impact on Serum Homocysteine in Hemodialysis Patients With Resistant Hypertension Phase 4